Several studies have indicated that the overexpression of APLP1 is significantly linked to a lower OS rate in the early stages of clear cell renal cell carcinoma, thus suggesting its potential as a biomarker for the aggressiveness and prognosis of the disease [59]. The gene discussed is APLP1; the disease is clear cell renal carcinoma.